Summary Blog: Detecting autism spectrum disorders: biomarker discoveries
Dr. Paige Siper
Dr. Siper is the Chief Psychologist of Seaver Autism Center for Research and Treatment at Mount Sinai, and an Assistant Professor in the Department of Psychiatry. She earned her PhD in Clinical Psychology from Yeshiva University completed her clinical psychology internship at the University of Miami Miller School of Medicine. She was the recipient of an Autism Speaks Meixner Translational Research Postdoctoral Fellowship, which she completed at Seaver Autism Center.
Dr. Siper’s research focuses on biomarker discovery and sensory processing using electrophysiological and behavioral approaches. Dr. Siper is the co-developer of the Sensory Assessment for Neurodevelopmental Disorders (SAND), which is the first clinician-administered observation and corresponding caregiver interview to quantify sensory reactivity according to DSM-5 criteria for autism spectrum disorder (ASD)
Dr. Siper’s research focuses on biomarker discovery and sensory processing using electrophysiological and behavioral approaches. Dr. Siper is the co-developer of the Sensory Assessment for Neurodevelopmental Disorders (SAND), which is the first clinician-administered observation and corresponding caregiver interview to quantify sensory reactivity according to DSM-5 criteria for autism spectrum disorder (ASD)
Detecting autism spectrum disorders: biomarker discoveries
A biomarker is “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to therapeutic intervention.” Biomarkers decrease our reliance on subjective patient, caregiver, or clinician ratings and are especially important for individuals who are unable to describe their physical or mental states.
.png)
No hay comentarios:
Publicar un comentario